Mycophenolate or mycophenolic acid

2-Iodo-3-methoxyphenol.

2-Iodo-3-methoxyphenol.

2-Iodo-6-methoxyphenol.

2-Iodo-6-methoxyphenol.

Cell Line Origin Mouse Sp2/0 x Mouse BALB/c spleen Cell Line Description The antibody recognises the human p62c-myc gene product. It is specific for the peptide D sequence and cross reacts with the p64/66 gene product of the mouse c-myc gene.

Mycophenolic acid is an active metabolite of the ester prodrug mycophenolate mofetil (MPM), which is prescribed as an immunosuppressant to prevent the organ transplantation rejection and also in the treatment of certain autoimmune diseases.

Application Mycophenolic acid (MPA), produced by Penicillum brevi-compactum , is a selective inhibitor of inosine monphosphate dehydrogenase, thus inhibiting DNA synthesis in T and B lymphocytes. It has also been shown to act as an

Application Mycophenolic acid (MPA), produced by Penicillum brevi-compactum , is a selective inhibitor of inosine monphosphate dehydrogenase, thus inhibiting DNA synthesis in T and B lymphocytes. It has also been shown to act as an

Application Mycophenolic acid (MPA), produced by Penicillum brevi-compactum , is a selective inhibitor of inosine monphosphate dehydrogenase, thus inhibiting DNA synthesis in T and B lymphocytes. It has also been shown to act as an

Application Mycophenolic acid (MPA), produced by Penicillum brevi-compactum , is a selective inhibitor of inosine monphosphate dehydrogenase, thus inhibiting DNA synthesis in T and B lymphocytes. It has also been shown to act as an

General description Mycophenolic acid (MPA), the active moiety of the prodrug mycophenolate mofetil, is widely used in immunosuppressive regimens after kidney, liver or heart transplantation. MPA is metabolized predominantly to the inactive

PrEST Antigen GTF3C2 general transcription factor IIIC, poly